Time Congress Acts As Drug Launch Prices Go Up 20% Annually
As many Americans face difficult financial decisions thanks to inflation, a new study verifies what many have feared for years: drug prices are significantly...
Alnylam Gives Findings of siRNA Delivery Outside of Liver
Alnylam has outlined their strategy for delivering siRNA to the central nervous system and other organs outside of the liver. The RNA specialist detailed...
Merck Sees 80 Plus Cancer Patents By 2028 Led By Keytruda
Merck & Co. was not at all a prominent oncology player before the advent of Keytruda. The New Jersey drugmaker wants to consolidate its supremacy...
Bispecific Blood Cancer Drug By Roche Globally Approved
Roche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a novel bispecific lymphoma medicine...
History Created- Every Patient In Drug Trial Is Cancer-Free
It was a small study, with only 18 rectal cancer sufferers taking the same medicine.
However, the outcomes were astounding. Every single patient's cancer vanished,...
Promising Findings of Drug Mix Targeting Cancers Death Star
The findings of a phase 1 trial examining a medication mixture targeting multiple mutant variants of cancer's 'death star' protein have been released by...
ICMR Issues Standards For Drones To Deliver Medical Supplies
The Indian Council of Medical Research, the country's apex agency for biomedical research, has issued guidelines for the use of drones in health.
WHAT IS...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...